JNJ·NYSEJohnson & Johnson
$157.25+1.99 (+1.28%)
Feb 14, 2025 at 00.17
Open155.26
High158.13
Low154.8
Vol10.22M
P/E27.158895
Mkt cap378.60B
52W H168.85
52W L140.68
Avg Vol8.70M
Div yield3.35%
Beta0.518
EPS5.79
Short Term High Open Interest Options
ContractJNJ Feb 21 2025 155 Call
Expiry2025-02-21
TypeCALL
Strike$155
Open Interest12171
Last Price$1.05
LEAP High Open Interest Options
ContractJNJ Jul 17 2026 180 Call
Expiry2026-07-17
TypeCALL
Strike$180
Open Interest462
Last Price$3.69
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, suc...
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Employees: 131,900
Website: https://www.jnj.com
Loading...